Women's Health

Study of 12.6 million births shows 36 percent jump in gestational diabetes during the past decade

From regulatory shifts to breakthrough diagnostics, the stories that defined clinical labs in 2025

If 2024 was defined by the looming threat of the FDA's "Final Rule" on laboratory-developed tests (LDTs), 2025 was defined by its sudden dismantling

Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression

Discontinuing GLP-1 drugs early in pregnancy may raise risks of weight gain, diabetes, hypertension, and preterm delivery

Newly identified F2R receptor shows promise for earlier detection and improved treatment outcomes

This is especially crucial for patients with treatment-resistant cancers and those with triple-negative breast cancer

Learn how rapid testing initiatives are addressing diagnostic delays in pregnancy and supporting earlier intervention against congenital syphilis

Findings pave way for more effective pregnancy management in higher risk patient population

Despite significant progress in recent years, it remains challenging to accurately identify the best treatments for individual patients and to predict cases with poorer prognosis

Clairity’s first FDA authorized AI platform for breast cancer prediction demonstrates consistent accuracy, real-world impact, and potential to transform global breast cancer screening

Targeted measures needed to boost attendance among initial non-attenders and reduce mortality risk, say researchers

With pregnancy supplement use at an all-time high, researchers say it’s time to revisit guidelines

Study highlights overlooked heart attack causes in adults under 65, challenging long-held beliefs and revealing risks of misdiagnosis

UCSF's Uma Mahadevan, MD, leads international consensus conference, with goal of improving treatment and outcomes for women with IBD and their children

The findings support further clinical studies to determine whether this marker may help identify patients who could benefit from CDK4/6 inhibitors

Study shows how tamoxifen may raise uterine cancer risk and points to a possible way to prevent it

How self-collection* and extended genotyping may help improve screening rates and support risk stratification

New study in Nature Communications highlights AI's role in transforming immunotherapy decisions and precision oncology

Offering HPV self-collection kits during routine GP appointments boosts screening rates among overdue women, helping prevent cervical cancer